{
    "2019-01-28": [
        [
            {
                "time": "2023-02-15",
                "original_text": "How Novartis Could Throw A Haymaker â€” And Slam Amgen's Sales",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Haymaker",
                        "Slam",
                        "Amgen",
                        "Sales"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-02-15",
                "original_text": "Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Q4",
                        "Earnings",
                        "Report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}